JAMA Medical News podcast

New GLP-1 Drug Options and More Highlights From the ADA's 2026 Scientific Sessions

0:00
22:49
15 Sekunden vorwärts
15 Sekunden vorwärts

Rita Kalyani, MD, chief scientific and medical officer at the American Diabetes Association, discusses the latest diabetes and obesity research, including a novel oral GLP-1 drug, a combined semaglutide-amylin analogue injection, data from China on high-dose mazdutide, and more.

Related Content:

Weitere Episoden von „JAMA Medical News“